Extracorporeal shockwave therapy

Bedrock Bioscience Announces Groundbreaking Medical Study Published in Prestigious Journal

Retrieved on: 
Thursday, December 21, 2023
Quality of life, Peripheral neuropathy, Research, Health, Platelet-rich plasma, Extracorporeal shockwave therapy, Medicine, University, Scientific Research Publishing, Molecular medicine, Combination, Patient, Canadian International Council, History, Oil lamp, Pharmaceutical industry

CLEARWATER, Fla., Dec. 20, 2023 /PRNewswire/ -- Bedrock Bioscience is thrilled to announce the publication of a groundbreaking medical study in the esteemed International Journal of Clinical Medicine.

Key Points: 
  • CLEARWATER, Fla., Dec. 20, 2023 /PRNewswire/ -- Bedrock Bioscience is thrilled to announce the publication of a groundbreaking medical study in the esteemed International Journal of Clinical Medicine.
  • This study marks a significant milestone in the field of Peripheral Neuropathy and reaffirms Bedrock's commitment to advancing medical knowledge and improving patient care.
  • Bedrock Bioscience is known for its commitment to scientific excellence and has a history of pioneering medical breakthroughs.
  • For more information about Bedrock Bioscience and its groundbreaking medical study, please visit www.bedrockbioscience.com/research or contact its media relations department at [email protected] .

Renowned Los Angeles Urologist, Dr. Justin Houman, Introduces Groundbreaking Shockwave Therapy for Erectile Dysfunction Treatment

Retrieved on: 
Thursday, June 8, 2023
Male, Reproductive medicine, University, Shock wave, Quality of life, American Urological Association, Erectile dysfunction, Blood, System, Suite, Medicine, Regeneration, Urology, Patient, Ronald Reagan UCLA Medical Center, Growth, Extracorporeal shockwave therapy, General surgery, Cedars-Sinai Medical Center, LOS, ED, Environment, International Society, Medical device

LOS ANGELES, June 8, 2023 /PRNewswire-PRWeb/ -- Dr. Justin Houman, a leading urologist based in Los Angeles, is thrilled to announce the integration of Shockwave Therapy for the treatment of Erectile Dysfunction (ED). With this cutting-edge treatment, Dr. Houman aims to provide patients with a highly effective, non-invasive solution to overcome the challenges of ED and regain their sexual confidence.

Key Points: 
  • Dr. Houman is now treating patients who are suffering from Erectile Dysfunction in Los Angeles with Shockwave Therapy which is a new Breakthrough Erectile Dysfunction Treatment that offers patients the opportunity to return to normal sexual function with their partner.
  • LOS ANGELES, June 8, 2023 /PRNewswire-PRWeb/ -- Dr. Justin Houman, a leading urologist based in Los Angeles , is thrilled to announce the integration of Shockwave Therapy for the treatment of Erectile Dysfunction (ED).
  • "I am thrilled to offer Shockwave Therapy as a safe and effective solution for men struggling with Erectile Dysfunction," said Dr. Houman.
  • Dr. Justin Houman's clinic is located at 8635 W 3rd St, Suite 1W in Los Angeles, CA.

SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference

Retrieved on: 
Thursday, April 27, 2023
DFU, PAU, Extracorporeal shockwave therapy, SAWC, ESWT, Health, Foot, OTCQB, TMI, The Michener Institute, SOC, DLS, Brazil, Regenerative medicine, WHS, Ministry, Ministry of Health, Welfare and Sport, Ministry of Trade, Industry and Energy, Hendricks, ICT, Microcirculation, EDEN, Plantar fasciitis, FDA, Standard of care, Ministry of Science and ICT, National Harbor, Maryland, Pharmaceutical industry, Nursing, Science, MD, Patient

EDEN PRAIRIE, MN, April 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce its participation in the upcoming 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) conference.

Key Points: 
  • EDEN PRAIRIE, MN, April 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce its participation in the upcoming 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) conference.
  • The SAWC Spring | WHS conference is the premier event dedicated to the management, treatment, and prevention of wounds, and brings together leading wound care experts from around the world.
  • The conference offers an opportunity for participants to share ideas and learn about the latest advancements in wound care technology.
  • "We are excited to attend the 2023 SAWC Spring | WHS conference and to participate in such an important event," said Tim Hendricks, Executive Vice President, Wound Care US of SANUWAVE Health.

SANUWAVE’s Energy First Technology to be Featured in 3 Clinical Posters at Upcoming 2022 Fall Symposium on Advanced Wound Care (SAWC)

Retrieved on: 
Wednesday, October 12, 2022
Caesars Palace, Plastic surgery, Skin, Park Manor, Trauma surgery, 2021 Essex County Council election, Use, Pontifical university, The Heights, EDEN, Private Securities Litigation Reform Act, Company, Marketing, GLOBE, Regenerative medicine, CRO, Hospital, Health, Research, Regeneration, Security (finance), ESWT, U.S. Securities and Exchange Commission, General surgery, PACE, Wound healing, Patient, Poster, SAWC, MD, Extracorporeal shockwave therapy, PUC, Forward-looking statement, Medicine, Medical imaging, Pharmaceutical industry, PLLC, Erythromelalgia

The conference is one of wound cares most esteemed events and will take place at Caesars Palace, Las Vegas, Nevada from October 13-16, 2022.

Key Points: 
  • The conference is one of wound cares most esteemed events and will take place at Caesars Palace, Las Vegas, Nevada from October 13-16, 2022.
  • The following clinical cases, which examine the use of dermaPACE in patients with chronic, complex, and challenging wounds, will be presented.
  • The Use of Non-Invasive Extracorporeal Shockwave Therapy (ESWT) Pulsed Acoustic Cellular Expression (PACE) System In Complex Wounds Related To Erythromelalgia, A Rare Skin Condition.
  • SANUWAVEs end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the bodys normal healing processes.

ELNA Medical Expands Its Presence in Ottawa-Gatineau Area with Opening of New Sexual Wellness Clinic

Retrieved on: 
Tuesday, March 1, 2022
Health, Laboratory, Man, ELNA, COVID-19, Capital region, Founder, Peyronie's disease, Joint Task Force National Capital Region Medical, Woman, Capital city, Extracorporeal shockwave therapy, Erectile dysfunction, Shock wave, Urology, Pharmaceutical industry, Birth control

MONTREAL, March 1, 2022 /CNW Telbec/ - Montreal-based ELNA Medical ("ELNA"), Canada's largest integrated network of medical clinics, announced today its expansion into the National Capital Region with the launch of its new men's sexual wellness clinic in Gatineau.

Key Points: 
  • MONTREAL, March 1, 2022 /CNW Telbec/ - Montreal-based ELNA Medical ("ELNA"), Canada's largest integrated network of medical clinics, announced today its expansion into the National Capital Region with the launch of its new men's sexual wellness clinic in Gatineau.
  • Comprised of three clinics operated by world-class specialists, ELNA Sexual Wellness is Canada's only network of clinics to offer a comprehensive suite of urology and sexual wellness treatments for both men and women.
  • "ELNA Sexual Wellness is delighted to bring its expertise, as well as our innovative treatments, including Shockwave Therapy and the P-Shot, to men in the Nation Capital Region.
  • For more information about ELNA Sexual Wellness:
    ELNA Medical is Canada's largest integrated network of medical clinics.

Dr. Wolfgang Schaden Named International Medical Director for SoftWave Tissue Regeneration Technologies Effective March 1, 2022

Retrieved on: 
Tuesday, March 1, 2022
GLOBE, International Society, Extracorporeal shockwave therapy, Workers Compensation Board of Manitoba, Trauma, International Medical Commission on Bhopal, Medical director, European Society of Gene and Cell Therapy, Bone, Workforce, FDA, Patient, Technology, Knowledge, MD, Research, CEO, Hospital

ATLANTA, March 01, 2022 (GLOBE NEWSWIRE) -- Wolfgang Schaden, MD, of Vienna, Austria, is retiring as Medical Director of the Austrian AUVA (Austrian Workers' Compensation Board) in Vienna and taking on a new role as International Medical Director for SoftWave Tissue Regeneration Technologies.

Key Points: 
  • ATLANTA, March 01, 2022 (GLOBE NEWSWIRE) -- Wolfgang Schaden, MD, of Vienna, Austria, is retiring as Medical Director of the Austrian AUVA (Austrian Workers' Compensation Board) in Vienna and taking on a new role as International Medical Director for SoftWave Tissue Regeneration Technologies.
  • His upcoming responsibilities are to recruit and oversee research partners and projects to advance SoftWave therapy and ensure SoftWave maintains its leadership role in international shockwave research.
  • Dr. Schaden will continue to practice SoftWave therapy at his medical practice in Vienna and will maintain his role as the Medical Director of a spine trauma study currently underway at 13 European trauma centers.
  • This study will serve as the basis of SoftWave's scheduled 2023 FDA filing for clearance to treat acute spine trauma.

Global Ultrasound Device Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022
Medical Devices, Health, CAGR, Technology, HIFU, ESWL, GE Healthcare, Adoption, Degenerative disease, Health, Artery, Tissue, Extracorporeal shockwave therapy, Asia-Pacific, Diagnosis, Artificial intelligence, Cancer, Neoplasm, Prevalence, Conditional sentence, Medical imaging, Ultrasound

An increase in the adoption of ultrasound devices for diagnosis and treatment is driving the market.

Key Points: 
  • An increase in the adoption of ultrasound devices for diagnosis and treatment is driving the market.
  • In addition, a rise in the adoption of minimally invasive surgeries, coupled with technological advancements, is expected to boost market growth.
  • Hand-held ultrasound devices have made the technology more accessible for use in limited-resource communities around the world.
  • Asia Pacific is anticipated to expand at the fastest CAGR over the forecast period owing to the increased demand for better imaging devices

Promaxo Announces Sale of In-Office MRI to Kasraeian Urology

Retrieved on: 
Tuesday, January 4, 2022
General Health, Medical Devices, Other Health, Health, Radiology, Prostate cancer, AI, Magnetic resonance imaging, MRI, HIFU, Company, Kidney, Cancer, Aquablation therapy, Prostate, Robotics, BPH, FACS, CEO, Hospital, FDA, Woman, Partnership, Diagnosis, Sale, Extracorporeal shockwave therapy, Bladder cancer, Technology, Urology, Man, Medical imaging, Kasraeian Urology, A Division of Florida Physician Specialists, Promaxo, Inc., KASRAEIAN UROLOGY, A DIVISION OF FLORIDA PHYSICIAN SPECIALISTS, PROMAXO, INC.

Promaxo, Inc. (Promaxo or the Company), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Kasraeian Urology, a Division of Florida Physician Specialists (Kasraeian Urology).

Key Points: 
  • Promaxo, Inc. (Promaxo or the Company), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Kasraeian Urology, a Division of Florida Physician Specialists (Kasraeian Urology).
  • Dr. Ali Kasraeian, FACS at Kasraeian Urology said, Our practice is dedicated to providing the most current and accurate tools and techniques for identifying and treating prostate cancer.
  • Kasraeian Urology is a family-owned practice providing personalized urologic care for over 25 years, with three offices in Northeast Florida.
  • Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform.

Global Tendinopathy Market to 2030 - Insights, Epidemiology and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 25, 2021
Health, Pharmaceutical, ROA, Review, Risk, European, Extracorporeal shockwave therapy, Population, Exercise, Diagnosis, Palpation, SWOT, Report, Achilles tendon, Epidemiology, ESWT, Research, Incidence, United Kingdom, MRI, III, Tendon, Physical examination, MOA, Bursitis, Pathology, Pharmaceutical industry, Medical imaging

The "Tendinopathy - Market Insight, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Tendinopathy - Market Insight, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's offering.
  • This report delivers an in-depth understanding of the Tendinopathy, historical and forecasted epidemiology as well as the Tendinopathy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
  • The Tendinopathy market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Tendinopathy market size from 2018 to 2030.
  • The Report also covers current Tendinopathy treatment practice, market drivers, market barriers, SWOT analysis, reimbursement, and market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

EDAP TMS SA to Announce First Quarter 2021 Financial Results on May 11, 2021

Retrieved on: 
Tuesday, May 4, 2021
Medicine, Clinical medicine, Branches of biology, Medical ultrasonography, Lithotripsy, Extracorporeal shockwave therapy, Therapeutic ultrasound, XC2, High-intensity focused ultrasound, Prostate

b'A recognized leader in the global therapeutic ultrasound market,\xc2\xa0EDAP TMS\xc2\xa0develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology.

Key Points: 
  • b'A recognized leader in the global therapeutic ultrasound market,\xc2\xa0EDAP TMS\xc2\xa0develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology.
  • With the addition of the ExactVu\xe2\x84\xa2 Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer.
  • EDAP TMS also produces and distributes other medical equipment including the Sonolith\xc2\xae i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL).
  • For more information on the Company, please visit http://www.edap-tms.com , and us.hifu-prostate.com .\n'